Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion type Assertion NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_head.
- NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion description "[The GG recessive genotype at CCL2 -2518bp was more common in patients with ML (N=67) than in neighborhood control (NC; N=60) subjects (OR 1.78; 95% CI 1.01-3.14; P=0.045), than in NC combined with leishmanin skin-test positive (N=60) controls (OR 4.40; 95% CI 1.42-13.65; P=0.010), and than in controls combined with CL (N=60) patients (OR 2.78; 95% CI 1.13-6.85; P=0.045).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_provenance.
- NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion evidence source_evidence_literature NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_provenance.
- NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion SIO_000772 20430117 NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_provenance.
- NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion wasDerivedFrom befree-20140225 NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_provenance.
- NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_assertion wasGeneratedBy ECO_0000203 NP429953.RAeUBe25b3Ap7pOfR3DdyDOo7uJf0p7gFcZOmdw4NtzZM130_provenance.